QS Investors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

QS Investors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,000	Closed	-$273K	–	1289
2020 Q3	$273K	Sell	2,000 -7,890	-80%	-$839K	﹤0.01%	961
2020 Q2	$956K	Buy	9,890 +9,490	+2,373%	+$792K	0.01%	733
2020 Q1	$19K	Sell	400 -1,500	-79%	-$96.1K	﹤0.01%	1486
2019 Q4	$137K	Hold	1,900	–	–	﹤0.01%	1289
2019 Q3	$100K	Buy	+1,900	New	+$101K	﹤0.01%	1388

QS Investors's MYOK Position: Q4 2020 in Review

QS Investors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 2,000 shares — an estimated $273K sold.

QS Investors first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $956K in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

QS Investors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
QS Investors sold 2,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $273K.
QS Investors first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
QS Investors's MyoKardia, Inc. Common Stock position peaked at $956K in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.